News

• 

  FDA approves first-of-its-kind treatment, Palforzia, for children with peanut allergies

  Palforzia is a newly approved medication that mitigates the consequences of  accidental exposure to peanuts. Dr. Wesley Burks and Dr. Edwin Kim,  members of  the UNC Children’s Research Institute, were key partners in spearheading the research that led to the development of this groundbreaking treatment.

• 

  Researchers at UNC use ‘biological flashlight’ to control living cells

  Antonio Amelio, PhD, researcher at UNC’s Lineberger Comprehensive Cancer Center, is part of a team that has created a new self-illuminating protein complex which removes the need for an external light source in optogenetics. This new discovery has the potential to give researchers better insight into cancer cell behaviors and future treatments.

• 

  Dr. Hongwei Du, postdoctoral fellow, has been awarded The Vicky Amidon Innovation in Lung Cancer Research Award

  Hongwei Du, PhD has been awarded $30,000 by The Lung Cancer Initiative of North Carolina (LCI) to research novel treatment targeting brain metastasis of non-small cell lung cancer. His research focuses on developing a new CAR-T immunotherapy which could transform the future of lung cancer treatment.

• 

  UNC Lineberger’s Dr. Emily Ray has been awarded the Young Investigator Award to support her work in breast cancer research

  The Conquer Cancer Foundation of the American Society of Clinical Oncology and the Breast Cancer Research Foundation have awarded Emily Ray, MD, MPH, $50,000 to support her work in developing predictive models to determine late stage breast cancer patient’s prognosis. This tool will assist with better treatment planning, which can be especially difficult as breast … Continued

Follow Us